However, in humans, significantly elevated serum adiponectin levels are reported in patients with chronic kidney diseases (CKD) or end-stage renal disease (ESRD) as well as in those who received dialysis or kidney transplants [9, 10]. Here, ADIPOQ is linked to chronic kidney disease.